Home > Analytics > MANGALAM DRUGS & ORGANICS

MANGALAM DRUGS & ORGANICS
Intrinsic Value | Fundamental Analysis

BOM : 532637     NSE : MANGALAM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Mar 20,2023
Price(EOD): ₹ 108.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 171.83 Cr
Value of ₹ 1 Lac invested in MANGALAM DRUGS & ORGANICS
on Mar 20,2018 (price: ₹ 170.00)

₹ 1 L

₹ 0.64 L

1W : -4.9% 1M : -4.1% 1Y : -4.5%
COMMUNITY POLL
for MANGALAM DRUGS & ORGANICS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
MANGALAM DRUGS & ORGANICS -4.9% -4.1% -4.5%
SUN PHARMACEUTICAL INDUSTRIES 0.4% -3.5% 7.8%
DIVIS LABORATORIES 1.5% -2.7% -36.6%
CIPLA -0.6% -16.3% -17.2%
DR REDDYS LABORATORIES 2.1% -1.7% 12.5%
TORRENT PHARMACEUTICALS 0.1% 0.9% 7.5%
ABBOTT INDIA 4.7% 4.4% 20.6%
ZYDUS LIFESCIENCES 1.1% -0.3% 27.1%
ALKEM LABORATORIES 0.6% -6% -8.9%

FUNDAMENTAL ANALYSIS OF MANGALAM DRUGS & ORGANICS

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF MANGALAM DRUGS & ORGANICS

 
Valuation Score
[As on : Mar 20,2023 ]

Ratio Standalone
P/E
P/B
P/S
13.94
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 12.35 Cr
[Latest Qtr - Dec2022 - Standalone Results ]

1.14
P/B Calculated based on Book Value of Rs 150.56 Cr
[Latest Year - Mar2022 - Standalone Results ]

0.43
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 31% undervalued companies ! Discover More →

FAIR VALUE OF MANGALAM DRUGS & ORGANICS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-16%
18%
146%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MANGALAM DRUGS & ORGANICS



MANGALAM DRUGS & ORGANICS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MANGALAM DRUGS & ORGANICS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.52
0.49
0.48
0.5
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MANGALAM DRUGS & ORGANICS

Pledged Promoter Shares
16.65 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MANGALAM DRUGS & ORGANICS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-41.54%
-23.29%
-83.92%
-80.91%
-37.84%
-54.8%
-94.39%
-89.43%
QtrlyTrend
-8
Latest Qtr: Dec2022
Quarterly Result Analysis →


MANGALAM DRUGS & ORGANICS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about MANGALAM DRUGS & ORGANICS


Is MANGALAM DRUGS & ORGANICS good for long term investment?

As on Mar 20,2023, the Fundamentals of MANGALAM DRUGS & ORGANICS look Poor and hence it may not be good for long term investment ! See Financial Performance of MANGALAM DRUGS & ORGANICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MANGALAM DRUGS & ORGANICS UnderValued or OverValued?

As on Mar 20,2023, MANGALAM DRUGS & ORGANICS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MANGALAM DRUGS & ORGANICS ?

As on Mar 20,2023, the Intrinsic Value of MANGALAM DRUGS & ORGANICS is Rs. 91.80 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 128.83
Fair Value [Median EV / Sales Model] : Rs. 91.80
Fair Value [Median Price / Sales Model] : Rs. 44.29
Estimated Median Fair Value of MANGALAM DRUGS & ORGANICS : Rs. 91.80

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is MANGALAM DRUGS & ORGANICS trading at a Premium or Discount?

As on Mar 20,2023, MANGALAM DRUGS & ORGANICS is trading at a Premium of 18% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].